Abstract
Psoriatic arthritis (PsA) patients are at a higher risk of systemic inflammatory sequelae, leading to microalbuminuria, cardiovascular (CVD) and neuropsychiatric (NPD) disease. Our aim is to present the existing literature about the relationship between CVD, kidney and NPD in PsA. The literature evaluation of PsA revealed that chronic T-cell activation and increased levels of circulating immune complexes can cause glomerular injury leading to microalbuminuria, which predicts CVD and all-cause mortality in both diabetic and non-diabetic patients. Furthermore, it is a marker of preclinical brain damage and identifies patients at higher risk of NPD/CVD events. Among the currently used imaging modalities in PsA, magnetic resonance imaging (MRI) maintains a crucial role, because it is ideal for concurrent evaluation of brain/heart involvement and serial follow up assessment. There is increasing evidence regarding the relationship between kidneys, heart and brain in PsA. Although currently there are no official recommendations about a combined brain/heart MRI in PsA, it could be considered in PsA with microalbuminuria, arrhythmia, HF, cognitive dysfunction and/or depression.
Similar content being viewed by others
References
Langley RGB, Krueger GG, Griffiths CEM (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 64:ii18–ii23
Mease P, Gladman D, Papp K et al (2013) Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 69(5):729–735
Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP, Egeberg A (2019) Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 80(1):251–265.e19
Veale DJ (2013) Psoriatic arthritis: recent progress in pathophysiology and drug development. Arthritis Res Ther 15:224
Jamnitski A, Visman IM, Peters MJL, Boers M, Dijkmans BAC, Nurmohamed MT (2011) Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis. Ann Rheum Dis 70(5):875–876
Koraboev E (2016) Renal disorders in patients with psoriatic arthritis. Ann Rheum Dis 75:1153
Khan A, Haider I, Ayub M, Humayun M (2017) Psoriatic arthritis is an indicator of significant renal damage in patients with psoriasis: an observational and epidemiological study. Int J Inflam 2017:5217687
Kotsis K, Voulgari PV, Tsifetaki N, Machado MO, Carvalho AF, Creed F, Drosos AA, Hyphantis T (2012) Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res (Hoboken) 64(10):1593–6019
Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417
Husted JA, Thavaneswaran A, Chandran V et al (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 63(12):1729–1735
Khalid U, Ahlehoff O, Gislason GH, Kristensen SL, Skov L, Torp-Pedersen C, Hansen PR (2014) Psoriasis and risk of heart failure: a nationwide cohort study. Eur J Heart Fail 16(7):743–748
Dervisoglu E, Akturk AS, Yildiz K, Kiran R, Yilmaz A (2012) The spectrum of renal abnormalities in patients with psoriasis. Int Urol Nephrol 44(2):509–514
Singh NP, Prakash A, Kubba S et al (2005) Psoriatic nephropathy—does an entity exist? Ren Fail 27(1):123–127
Kurd SK, Gelfand JM (2009) The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol 60(2):218–224
González-Parra E, Daudén E, Carrascosa JM, Olveira A, Botella R, Bonanad C, Rivera R (2016) Kidney disease and psoriasis. A new comorbidity? Actas Dermosifiliogr 107(10):823–829
Diercks GFH, van Boven AJ, Hillege HL, Janssen WM, Kors TJA, de Jong PE et al (2000) Microalbuminuriais independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population the PREVEND (Prevention of Renal and Vascular Endstage Disease) study. Eur Heart J 21(23):1922–1927.14
Festa A, Agostino R, Howard G, Mykkanen L, Tracy RP, Haffners M (2000) Inflammation and microalbuminuriain nondiabetic and type 2 diabetic subjects: the insulin resistance atherosclerosis study. Kidney Int 58(4):1703–1710.15
Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J (1993) A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 7:996–1003
Ravera M, Ratto E, Vettoretti S, Viazzi F, Leoncini G, Parodi D, Tomolillo C, Del Sette M, Maviglio N, Deferrari G, Pontremoli R (2002) Microalbuminuria and subclinical cerebrovascular damage in essential hypertension. J Nephrol 15:519–524
Ovbiagele B, Liebeskind DS, Pineda S, Saver JL (2010) Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack. Arch Neurol 67(1):45–50
Lee JL, Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L (2018) Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study. Arthritis Res Ther 20:171
Tam LS, Shang Q, Li EK et al (2008) Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum 59(9):1322–1331
Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA (2007) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Care Res 57(6):1074–1080
Svanteson M, Rollefstad S, Kløw NE, Jonny Hisdal J, Ikdahl E, Semb AG, Haig Y (2017) Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases. RMD Open 3(2):e000544
Cavalcante L, Lima JA, Redheuil A, Al-Mallah MH (2011) Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 57(14):1511–1522
Costa L, Caso F, D’Elia L et al (2012) Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol 31(4):711–715
Shang Q, Tam LS, Yip GW, Sanderson JE, Zhang Q, Li EK, Yu CM (2011) High prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritis. J Rheumatol 38(7):1363–1370
Lee E, Han JH, Bang CH, Yoo SA, Han KD, Kim HN, Park YM, Lee JY, Lee JH (2019) Risk of end-stage renal disease in psoriatic patients: real-world data from a nationwide population-based cohort study. Sci Rep 9(1):16581
Pana C, Hanzu-Pazara L, Duşa D, Tudorache M, Fasie D, Suta M, Tuta LA (2016) Renal comorbidity in psoriatic arthritis patients. ARS Med Tomitana 1(22):43–49
Wang CC, Tang CH, Huang KC, Huang SY, Sue YM (2018) Increased risk of incident psoriasis in end-stage renal disease patients on chronic hemodialysis: a nationwide population-based cohort study. J Dermatol 45(9):1063–1070
Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA et al (2006) Lack of echocardiographic and doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Semin Arthritis Rheum 35(5):333–339
Shang Q, Tam LS, Yip GWK et al (2011) High prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritis. J Rheumatol 38(7):1363–1370
Pines A, Ehrenfeld M, Fisman EZ (1986) Mitral valve prolapse in psoriatic arthritis. Arch Intern Med 146(7):1371–1373
Moya JL, Sanchez M, Morales MD, Brito E (1987) Mitral valve prolapse (MVP) in psoriatic arthritis (PA). Arch Intern Med 147(5):992
Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH, Kolovou G, Miszalski T, van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas G, Puntmann V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G, Koutsogeorgopoulou L, van Rossum A, Rademakers F, Pohost G, Lima JA (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135–148
Mavrogeni SI, Sfikakis PP, Markousis-Mavrogenis G, Bournia VK, Poulos G, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Katsifis G, Boki K, Vartela V, Kolovou G, Theodorakis G, Kitas GD (2019) Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction. Int J Cardiol 284:105–109
Markousis-Mavrogenis G, Mitsikostas DD, Koutsogeorgopoulou L, Dimitroulas T, Katsifis G, Argyriou P, Apostolou D, Velitsista S, Vartela V, Manolopoulou D, Tektonidou MG, Kolovou G, Kitas GD, Sfikakis PP, Mavrogeni SI (2020) Combined brain-heart magnetic resonance imaging in autoimmune rheumatic disease patients with cardiac symptoms: hypothesis generating insights from a cross-sectional study. J Clin Med 9(2):E447
Ntusi NA, Francis JM, Sever E, Liu A, Piechnik SK, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD (2018) Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases. Int J Cardiol 270:253–259
Szentpetery A, Brady D, Healy G, Redmond C, Fleming H, Duignan J, Haroon M, Dodd J, FitzGerald O (2016) Higher frequency and severity of coronary plaques on coronary ct angiography in psoriatic arthritis patients without symptoms of coronary artery disease compared to controls [abstract]. Arthritis Rheumatol 68 (suppl 10). https://acrabstracts.org/abstract/higher-frequency-and-severity-of-coronary-plaques-on-coronary-ct-angiographyin-psoriatic-arthritis-patients-without-symptoms-of-coronary-artery-disease-compared-to-controls/. Accessed 27 June 2020
Shen J, Wong K, Cheng IT et al (2017) Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease. Ann Rheum Dis 76:1237–1244
Kaur S, Shafiq N, Dogra S, Mittal BR, Attri SV, Bahl A, Narang T, Vinay K, Rajagopalan S, Malhotra S (2018) 18F-fluorodeoxyglucose positron emission tomography-based evaluation of systemic and vascular inflammation and assessment of the effect of systemic treatment on inflammation in patients with moderate-to-severe psoriasis: a randomized placebo-controlled pilot study. Indian J Dermatol Venereol Leprol 84(6):660–666
Feher A, Sinusas AJ (2017) Quantitative assessment of coronary microvascular function: dynamic single-photon emission computed tomography, positron emission tomography, ultrasound, computed tomography, and magnetic resonance imaging. Circ Cardiovasc Imaging 10(8):e006427. https://doi.org/10.1161/CIRCIMAGING.117.006427
Chen KT, Chen YC, Fan YH, Lin WX, Lin WC, Wang YH, Lin L, Chiou JY, Wei JC (2018) Rheumatic diseases are associated with a higher risk of dementia: a nation-wide, population-based, case-control study. Int J Rheum Dis 21(2):373–380
Gisondi P, Sala F, Alessandrini F, Avesani V, Zoccatelli G, Beltramello A, Moretto G, Gambina G, Girolomoni G (2014) Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis. Dermatology 228:78–85
Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16(1):22–34
Wiseman SJ, Ralston SH, Wardlaw JW (2016) Cerebrovascular disease in rheumatic diseases. A systematic review and meta-analysis. Stroke 47:943–950
Cho E, Shin H, Park S et al (2016) Albuminuria, cerebrovascular disease and cortical atrophy: among cognitively normal elderly individuals. Sci Rep 6:20692
Mavrogeni S, Koutsogeorgopoulou L, Dimitroulas T, Markousis-Mavrogenis G, Boki K, Katsifis G, Vartela V, Kallenberg CG, Kolovou G, Kitas G (2019) Combined brain/heart magnetic resonance imaging in systemic lupus erythematosus. Curr Cardiol Rev. https://doi.org/10.2174/1573403X15666190801122105
Fuggle NR, Howe FA, Allen RL, Sofat N (2014) New insights into the impact of neuro-inflammation in rheumatoid arthritis. Front Neurosci 8:357
Berry C, Sidik N, Pereira AC, Ford TJ, Touyz RM, Kaski JC, Hainsworth AH (2019) Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions. J Am Heart Assoc 8(3):e011104
Funding
There is no financial support for this paper and no disclosure for any of the authors.
Author information
Authors and Affiliations
Contributions
All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. GM-M: draft design and writing. MTN: draft concept and design. LK: rheumatologic literature evaluation. TD: rheumatologic Literature evaluation. GK: rheumatologic literature evaluation. VV: cardiac imaging literature evaluation. DM: neurologic literature evaluation. GK: cardiologic and nephrologic literature evaluation. MT: discussion of rheumatic findings in PsA. PV: discussion of the correlation between rheumatic and nephrologic findings in PsA. PPS: discussion of the correlation between rheumatic, cardiac and nephrologic findings in PsA. GDK: discussion of the correlation between rheumatic, cardiac and nephrologic findings in PsA. SIM: overview, final organisation and writing of the paper.
Corresponding author
Ethics declarations
Ethical statement
In this review article sfpatients or the public were not involved in the design, or conduct, or reporting, or dissemination plans of our research.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Markousis-Mavrogenis, G., Nurmohamed, M.T., Koutsogeorgopoulou, L. et al. Current understanding and future perspectives of brain–heart–kidney axis in psoriatic arthritis. Rheumatol Int 40, 1361–1368 (2020). https://doi.org/10.1007/s00296-020-04633-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-020-04633-1